You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,166,722


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,166,722 protect, and when does it expire?

Patent 7,166,722 protects FOTIVDA and is included in one NDA.

This patent has ten patent family members in nine countries.

Summary for Patent: 7,166,722
Title:N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxaz- olyl)urea salt in crystalline form
Abstract: The present invention provides a crystal of a pharmaceutically acceptable salt of N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl- -3-isoxazolyl) urea. This crystal of salt is usable for the therapy of a disease selected from the group consisting of tumors, diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis, Kaposi's sarcoma, and exudation type age-related maculopathy, and has characteristics suitable for applications of oral pharmaceutical preparations.
Inventor(s): Matsunaga; Naoki (Gunma-Ken, JP), Yoshida; Satoshi (Gunma-Ken, JP), Yoshino; Ayako (Gunma-Ken, JP), Nakajima; Tatsuo (Gunma-Ken, JP)
Assignee: Kirin Beer Kabushiki Kaisha (Tokyo-To, JP)
Application Number:10/532,104
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,166,722: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing exclusive rights to inventors and companies for their intellectual property. The scope and claims of a patent are crucial in defining what is protected and what constitutes infringement. This article will delve into the specifics of United States Patent 7,166,722, analyzing its scope, claims, and the broader patent landscape it operates within.

Background on Patent Scope and Claims

Before diving into the specifics of the patent in question, it is essential to understand the general principles of patent scope and claims. Patent scope refers to the breadth of protection granted by a patent, which is determined by the language of the claims[3].

Claim Construction and Scope

The construction of patent claims is a critical step in determining the scope of a patent. Claims define the boundaries of what is protected and must be clear and specific to avoid ambiguity. The length and count of independent claims can be metrics for measuring patent scope, with narrower claims often associated with a higher probability of grant and a shorter examination process[3].

The Patent in Question: United States Patent 7,166,722

To analyze the scope and claims of United States Patent 7,166,722, we need to look at the specific claims and the context in which they are made.

Claim Analysis

  • Independent Claims: These are the broadest claims in a patent and set the outer limits of what is protected. For example, in pharmaceutical patents, independent claims might describe the composition and method of preparation of a drug[2].
  • Dependent Claims: These claims are narrower and depend on the independent claims. They often specify particular aspects or variations of the invention.

Claim Language and Scope

The language used in the claims is pivotal. For instance, product-by-process claims, which describe a product by the process used to make it, are only infringed if the product is made by the exact process recited in the claim[2].

Infringement and Validity

Infringement and validity are two key aspects that determine the effectiveness of a patent.

Infringement

Infringement occurs when someone makes, uses, offers to sell, or sells a patented invention without authority. The analysis involves construing the claims and comparing them with the accused infringing product. In cases like the Hatch-Waxman Act, the focus is on future conduct rather than past acts[2].

Validity

The validity of a patent can be challenged through oppositions or re-examinations. Valuable patents are more likely to be challenged, and the outcomes can significantly impact the patent's scope and existence. For example, oppositions at the European Patent Office (EPO) have a higher rate of revocation compared to re-examinations at the USPTO[4].

Biological Deposits and Patent Protection

In the context of biological materials, such as those involved in biotechnology and seed patents, the scope of protection can be particularly complex. Biological deposits are sometimes required to support patent claims, especially for self-replicating materials like seeds. This adds a layer of complexity due to the ease with which these materials can be replicated and potentially infringe on patents[1].

The Impact of Genus Claims

Historically, genus claims were common in chemical, biotechnology, and pharmaceutical patents, covering a group of related chemicals rather than a single specific compound. However, recent legal changes have made it nearly impossible to have valid genus claims, as courts often hold them invalid. This shift has significant implications for the scope and protection offered by patents in these fields[5].

Patent Landscape and Trends

The patent landscape is constantly evolving, influenced by legal changes, technological advancements, and economic factors.

Changes in Patent Scope

The examination process tends to narrow the scope of patent claims, with broader claims often facing longer examination periods and higher chances of being narrowed or rejected[3].

Opposition and Re-examination

The rates and outcomes of oppositions and re-examinations vary significantly between jurisdictions. For instance, the EPO sees a much higher rate of opposition and revocation compared to the USPTO[4].

Case Studies and Industry Insights

Real-world cases and industry insights provide valuable context for understanding the practical implications of patent scope and claims.

Example: United Therapeutics Corporation vs. Liquidia Technologies, Inc.

In this case, the dispute centered around the infringement and validity of patents related to the preparation of treprostinil, a drug used for pulmonary arterial hypertension. The court's analysis highlighted the importance of claim construction and the focus on the process of making the product as much as the product itself[2].

Key Takeaways

  • Claim Construction: Clear and specific claim language is crucial for defining the scope of a patent.
  • Infringement and Validity: These are critical aspects that determine the effectiveness of a patent, with infringement focused on future conduct in certain cases.
  • Biological Deposits: These add complexity to patent protection, especially for self-replicating materials.
  • Genus Claims: Recent legal changes have made valid genus claims nearly impossible, impacting the scope of protection in chemical, biotechnology, and pharmaceutical patents.
  • Patent Landscape: The scope of patent claims is influenced by the examination process, oppositions, and re-examinations, with significant variations between jurisdictions.

FAQs

  1. What is the significance of claim construction in patent law?

    • Claim construction is essential as it defines the boundaries of what is protected by a patent. Clear and specific language helps avoid ambiguity and ensures that the scope of protection is well-defined.
  2. How do biological deposits impact patent protection?

    • Biological deposits, especially for self-replicating materials like seeds, add complexity to patent protection. They require specific handling and can be easily replicated, which can lead to potential infringement issues.
  3. What is the current status of genus claims in patent law?

    • Genus claims, which cover a group of related chemicals, are no longer valid under current patent law. Courts almost always hold them invalid, significantly impacting the scope of protection in certain fields.
  4. How do oppositions and re-examinations differ between the EPO and USPTO?

    • Oppositions at the EPO have a higher rate of revocation compared to re-examinations at the USPTO. The EPO sees more frequent and successful challenges to patents, while the USPTO has a lower rate of patent revocation through re-examination.
  5. What metrics can be used to measure patent scope?

    • Metrics such as independent claim length and independent claim count can be used to measure patent scope. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments and forward citations[3].

Sources

  1. GAO Report on Biological Deposits: Deposits of Biological Materials in Support of Certain Patent Applications[1].
  2. District of Delaware Opinion: Civil Action No. 20-755-RGA[2].
  3. Hoover Institution Paper: Patent Claims and Patent Scope[3].
  4. NBER Working Paper: Post-Issue Patent “Quality”[4].
  5. Stanford Law School Article: The Death of the Genus Claim[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,166,722

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Aveo Pharms FOTIVDA tivozanib hydrochloride CAPSULE;ORAL 212904-001 Mar 10, 2021 RX Yes No ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
Aveo Pharms FOTIVDA tivozanib hydrochloride CAPSULE;ORAL 212904-002 Mar 10, 2021 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,166,722

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2002-306101Oct 21, 2002
PCT Information
PCT FiledOctober 21, 2003PCT Application Number:PCT/JP03/13439
PCT Publication Date:April 29, 2004PCT Publication Number: WO2004/035572

International Family Members for US Patent 7,166,722

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1559715 ⤷  Subscribe 2018/009 Ireland ⤷  Subscribe
Austria 374199 ⤷  Subscribe
Australia 2003301430 ⤷  Subscribe
Germany 60316590 ⤷  Subscribe
Denmark 1559715 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.